Michael Kahn
Engineers at Wacker Dr, Chicago, IL

License number
South Dakota 12806
Expiration Date
Jan 31, 2018
Category
Professional Engineer
Address
Address
125 S Wacker Dr SUITE 600, Chicago, IL 00666
Phone
(312) 780-7707

Professional information

Michael Kahn Photo 1

Vice Chairman Medical Oncology At Central Dupage Hospital

Position:
Medical Doctor at Cadence Health
Location:
Greater Chicago Area
Industry:
Health, Wellness and Fitness
Work:
Cadence Health - Central DuPage Hospital since Jul 2011 - Medical Doctor Central DuPage Hospital Jan 1999 - Nov 2012 - Vice Chairman Medical Oncology Cancer Care and Hematology Specialists of Chicagoland Aug 1995 - Jul 2011 - Physician partner Glen Ellyn Clinic/DuPage Medical Group - Glen Ellyn, Illinois Aug 1988 - Aug 1993 - Physician Partner
Education:
Rush Medical College of Rush University Medical Center 1993 - 1995
Medical Fellowship, Medical Oncology Residency Program
University of Illinois College of Medicine 1985 - 1988
University of Illinois College of Medicine 1981 - 1985
Doctor of Medicine (MD), Medicine
University of Illinois at Urbana-Champaign 1977 - 1981
Bachelor of Science (BS), Psychology


Michael Kahn Photo 2

Ceo At Genesis Technologies

Position:
CEO at Genesis Technologies
Location:
Greater Chicago Area
Industry:
Business Supplies and Equipment
Work:
Genesis Technologies - CEO


Michael Kahn Photo 3

Michael Kahn

Location:
Greater Chicago Area
Industry:
Marketing and Advertising


Michael Kahn Photo 4

Michael Kahn

Location:
Greater Chicago Area
Industry:
Computer Networking


Michael Kahn Photo 5

Compositions Which Are Immunologically Crossreactive With Antibodies And Preparative Methods Therefor

US Patent:
5334702, Aug 2, 1994
Filed:
Aug 20, 1992
Appl. No.:
7/933013
Inventors:
Mark I. Greene - Penn Valley PA
Horacio U. Saragovi - Philadelphia PA
Michael Kahn - Chicago IL
Assignee:
University of Illinois - Champaign IL
Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
C07K 702, C07K 750, C07D24500
US Classification:
530323
Abstract:
Compositions which are immunologically crossreactive with antibodies are provided, together with preparative and therapeutic methods therefor. The compositions preferably comprise a plurality of covalently bound synthetic compounds, at least one of which is individually crossreactive with at least one complementarity determining region (CDR) of the antibody. Preferred processes for preparing the immunologically crossreactive compounds comprise identifying chemical functionality such as hydroxyl groups in the CDR which participates in at least one immunological binding phenomena, determining the three-dimensional positioning of the chemical functionality, and synthesizing a compound which comprises substantially the same chemical functionality as the CDR and which has at least one conformation wherein the three-dimensional positioning of the chemical functionality is substantially identical to the three-dimensional positioning of the chemical functionality of the CDR.


Michael Kahn Photo 6

Confomationally Restricted Mimetics Of Beta Turns And Beta Bulges And Peptides Containing The Same

US Patent:
5670155, Sep 23, 1997
Filed:
Jun 6, 1995
Appl. No.:
8/473401
Inventors:
Michael Kahn - Chicago IL
Assignee:
Molecumetics, Ltd. - Bellevue WA
International Classification:
A61K 3921, A61K 3812
US Classification:
4242081
Abstract:
The invention provides materials and methods for synthesizing novel reverse turn mimetics, as well as peptides containing the same. Also provided are novel synthetic nonpeptide therapeutic molecules designed upon the interactions between reverse turn mimetics or peptides containing the same, and receptors, antibodies, or enzymes.


Michael Kahn Photo 7

Conformationally Restricted Mimetics Of Beta Turns And Beta Bulges And Peptides Containing The Same

US Patent:
5440013, Aug 8, 1995
Filed:
Mar 9, 1994
Appl. No.:
8/208801
Inventors:
Michael Kahn - Chicago IL
Assignee:
The Board of Trustees of the University of Illinois - Champagne IL
International Classification:
A61K 3800, C07K 500, C07K 700, C07K 1700
US Classification:
530317
Abstract:
The invention provides materials and methods for synthesizing novel beta-turn mimetics, as well as the novel beta-turn mimetics themselves, and peptides containing the same. Also provided are novel synthetic nonpeptide therapeutic molecules designed upon the interactions between beta-turn mimetics or peptides containing the same, and receptors or enzymes.


Michael Kahn Photo 8

Conformationally Restricted Mimetics Of Beta Turns And Beta Bulges And Peptides Containing The Same

US Patent:
5618914, Apr 8, 1997
Filed:
Jun 6, 1995
Appl. No.:
8/484060
Inventors:
Michael Kahn - Chicago IL
Assignee:
Molecumetics, Ltd. - Bellevue WA
International Classification:
A61K 3812, C07K 102
US Classification:
530317
Abstract:
The invention provides materials and methods for synthesizing novel beta-turn mimetics, as well as the novel beta-turn mimetics themselves, and peptides containing the same. Also provided are novel synthetic nonpeptide therapeutic molecules designed upon the interactions between beta-turn mimetics or peptides containing the same, and receptors or enzymes.


Michael Kahn Photo 9

Michael Kahn

Location:
Greater Chicago Area
Industry:
Publishing


Michael Kahn Photo 10

Michael Kahn

Location:
Greater Chicago Area
Industry:
Civil Engineering